Joseph DeRisi, PhD, and Allison Doupe, MD, PhD were honored by the National Academy of Sciences for their “extraordinary scientific achievements” yesterday. They join 13 others in the fields of physical, biological and social sciences.
January 17, 2014
December 18, 2013
Experts across UCSF weigh in on what some of 2014's top trends are in research and patient care.
December 17, 2013
A team led by scientists from UCSF has discovered that recurrent gliomas may have genetic profiles that are markedly different from those of the initial tumors that spawned them.
November 15, 2013
Precision Medicine Pillar No. 5: Omics Medicine. Molecular biologist Nevan Krogan's work is not only illuminating how genes and proteins function, it's also shedding light on the underlying biology of disease for each person.
November 15, 2013
Precision Medicine Pillar No. 4: Computational Health Sciences. Computationally intensive approaches are used to analyze and cross-analyze large but discrete collections of data, such as patient health histories and genetic makeup.
November 14, 2013
With inexpensive genetics kits flooding the market, both consumers — and their doctors — still lack basic information about what to do, if anything, with what they learn about their own genomes.
November 11, 2013
Researchers at the UCSF-affiliated Gladstone Institutes have discovered how the activation of specific stretches of DNA control the development of uniquely human characteristics.
October 16, 2013
A UCSF-led team of scientists has discovered that a gene mutation found in some bladder cancers is indicative of low-risk tumors that are unlikely to recur or progress after surgery.
September 04, 2013
UCSF will receive $4.5 million for a pilot project to assess whether large-scale gene sequencing can and should become a routine part of newborn testing.
August 12, 2013
Researchers have probed deep into the cell’s genome to begin learning the “grammar” that helps determine whether or not a gene gets switched on to make the protein it encodes, advancing efforts to use gene and cell-based therapies to treat disease.